Literature DB >> 18507662

Haemoptysis associated with gatifloxacin in a 27 year old male asthmatic--a case report.

Varun Gupta, Waseem Rizvi, Khurshid A Dar, Rakesh Bhargava, Anil Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18507662      PMCID： PMC2485260          DOI： 10.1111/j.1365-2125.2008.03171.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

Review 1.  Quinolone generations: natural history or natural selection?

Authors:  P Ball
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

2.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

3.  Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.

Authors:  Scott Mathews; Jean Cole; Russell A Ryono
Journal:  Pharmacotherapy       Date:  2006-10       Impact factor: 4.705

Review 4.  Gatifloxacin.

Authors:  C M Perry; J A Barman Balfour; H M Lamb
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital.

Authors:  B Hirshberg; I Biran; M Glazer; M R Kramer
Journal:  Chest       Date:  1997-08       Impact factor: 9.410

6.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.